These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36520086)

  • 1. Impaired FXR-CPT1a signaling contributes to parenteral nutrition-induced villus atrophy in short-bowel syndrome.
    Zhao Y; Feng H; Wang Y; Jiang L; Yan J; Cai W
    FASEB J; 2023 Jan; 37(1):e22713. PubMed ID: 36520086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
    Villalona G; Price A; Blomenkamp K; Manithody C; Saxena S; Ratchford T; Westrich M; Kakarla V; Pochampally S; Phillips W; Heafner N; Korremla N; Greenspon J; Guzman MA; Kumar Jain A
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1238-1251. PubMed ID: 29701901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders.
    Cerdó T; García-Santos JA; Rodríguez-Pöhnlein A; García-Ricobaraza M; Nieto-Ruíz A; G Bermúdez M; Campoy C
    Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome.
    Proli F; Faragalli A; Talbotec C; Bucci A; Zemrani B; Chardot C; Abi Nader E; Goulet O; Lambe C
    Clin Nutr; 2021 Aug; 40(8):4941-4947. PubMed ID: 34358840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury.
    Madnawat H; Welu AL; Gilbert EJ; Taylor DB; Jain S; Manithody C; Blomenkamp K; Jain AK
    Nutr Clin Pract; 2020 Feb; 35(1):63-71. PubMed ID: 31872510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition.
    Jain AK; Wen JX; Blomenkamp KS; Arora S; Blaufuss TA; Rodrigues J; Long JP; Neuschwander-Tetri BA; Teckman JH
    JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):67-72. PubMed ID: 25921560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short bowel syndrome: highlights of patient management, quality of life, and survival.
    Kelly DG; Tappenden KA; Winkler MF
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.
    Tsikis ST; Fligor SC; Mitchell PD; Hirsch TI; Carbeau S; First E; Loring G; Rudie C; Freedman SD; Martin CR; Gura KM; Puder M
    PLoS One; 2023; 18(3):e0282248. PubMed ID: 36857339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
    Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
    Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.
    Messing B; Crenn P; Beau P; Boutron-Ruault MC; Rambaud JC; Matuchansky C
    Gastroenterology; 1999 Nov; 117(5):1043-50. PubMed ID: 10535866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world etiologies and treatments of pediatric short bowel syndrome in Japan.
    Tazuke Y; Udagawa E; Mizushima T; Nakamura S; Fernandez J; Okuyama H
    Pediatr Int; 2022 Jan; 64(1):e15258. PubMed ID: 36163637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of various pediatric short bowel syndrome in China.
    Zhang T; Feng H; Cao Y; Tao Y; Lu L; Yan W; Li F; Wang Y; Cai W
    Pediatr Surg Int; 2021 Apr; 37(4):495-502. PubMed ID: 33394086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
    Strang BJ; Reddix BA; Wolk RA
    Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: Parenteral nutrition or intestinal transplantation.
    Norsa L; Artru S; Lambe C; Talbotec C; Pigneur B; Ruemmele F; Colomb V; Capito C; Chardot C; Lacaille F; Goulet O
    Clin Nutr; 2019 Apr; 38(2):926-933. PubMed ID: 29478887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.
    Pereira-Fantini PM; Lapthorne S; Gahan CGM; Joyce SA; Charles J; Fuller PJ; Bines JE
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):65-74. PubMed ID: 28560290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation.
    Xu S; Jia P; Fang Y; Jin J; Sun Z; Zhou W; Li J; Zhang Y; Wang X; Ren T; Zou Z; Ding X
    Kidney Int; 2022 May; 101(5):987-1002. PubMed ID: 35227690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses.
    Namgaladze D; Lips S; Leiker TJ; Murphy RC; Ekroos K; Ferreiros N; Geisslinger G; Brüne B
    Diabetologia; 2014 May; 57(5):1067-77. PubMed ID: 24488024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.